1 Letterman Drive, Ste D3500 San Francisco, CA 94129 parkerici.org
Note: Revenues for privately held companies are statistical evaluations.
Parker Institute For Cancer Immunotherapy's annual revenues are $1-$10 million (see exact revenue data) and has 10-100 employees. It is classified as operating in the Scientific Research & Development Services industry.
Parker Institute For Cancer Immunotherapy's Annual Report & Profile shows critical firmographic facts:
What is the company's size? (Annual sales and employees)
What industry is the company in?
Parker Institute For Cancer Immunotherapy Annual Revenue and Growth Rate
Note: Parker Institute For Cancer Immunotherapy's revenues are gauged from an analysis of company filings.
Parker Institute For Cancer Immunotherapy's Income Statement (based on Industry Averages)
$ Millions (Industry Average)
Parker Institute For Cancer Immunotherapy Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Parker Institute For Cancer Immunotherapy is developing and marketing.
Parker Institute For Cancer Immunotherapy's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
FROM BENCH TO FIRESIDE Podcasting services in the fields of scientific and medical research and research projects, medical and scientific clinical trials as well as information in the field of medicine, and medical conditions and treatments
10/18/2023
PICI Capital investment services; providing grants and funding of scientific and medical research and research projects; charitable foundation services to fund scientific and medical research and research projects
09/11/2023
See all trademarks and details in the Full Report.
Recession Risk
Determine whether Parker Institute For Cancer Immunotherapy grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Parker Institute For Cancer Immunotherapy is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Parker Institute For Cancer Immunotherapy's Largest Competitors
A competitive analysis shows these companies are in the same general field as Parker Institute For Cancer Immunotherapy, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Parker Institute For Cancer Immunotherapy.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
Future Competition: Parker Institute For Cancer Immunotherapy's Fastest Growing Competitors
These companies are in the same general field as Parker Institute For Cancer Immunotherapy and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.